Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

306.37
Delayed Data
As of 4:00pm ET
 +6.21 / +2.07%
Today’s Change
13.10
Today|||52-Week Range
325.98
+233.77%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 306.50, with a high estimate of 400.00 and a low estimate of 300.00. The median estimate represents a +0.04% increase from the last price of 306.37.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.64
Sales
$0.00
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -42.59%
 
 
 
 
 
 
Growthannually -6.82%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.